[Elsevier] Efficacy and Safety of Azacitidine in Patients With RUNX1::RUNX1T1 Measurable Residual Disease-Positive Acute Myeloid Leukemia After Consolidation Therapy Who Did Not Undergo Allogeneic Hematopoietic Stem-Cell Transplantation |
|
This post will be closed automatically in 2026-10-26 18:21
Best Answer
6 day(s) ago
|
| |
post
reply
points
20
10
Transition metals-doped g-C3N4 nanostructures as advanced photocatalysts for energy and environmental applications
30
Regulating Na/NASCION electrolyte interface chemistry for stable solid-state Na metal batteries at room temperature
200
[Full book]Sustainable Quality Improvements for Isotope Dilution in Molecular Ultratrace Analyses
10
FRAPE: A Framework for Risk Assessment, Prioritization and Explainability of vulnerabilities in cybersecurity
